Business Context and Reporting Period
This Form 8-K Current Report is filed by Global Medical REIT Inc. (the "Company") on June 17, 2016, covering events occurring on June 13, 2016, and June 15, 2016. The Company is a Maryland corporation preparing for an underwritten public offering (IPO) of 9,100,000 shares of common stock. Note: The request metadata references "Chiron Real Estate Inc.," but the filing text explicitly identifies the registrant as Global Medical REIT Inc.
Key Financial Metrics and Agreements
The filing details a material definitive agreement regarding the Company's debt structure prior to its IPO:
- Convertible Debentures: Aggregate principal amount outstanding of $25,030,134 owed to ZH USA, LLC (majority stockholder).
- Pay-Off Amount: Upon IPO closing, the Company will pay $10,000,000 in cash to the Lender.
- Conversion Amount: The remaining principal of $15,030,134 will be converted into common stock and limited partnership units.
- Conversion Rate: $12.748 per Share or Unit.
- Accrued Interest: $1,590,632 accrued as of June 15, 2016, plus $5,486.06 per day until the Pay-Off and Conversion are completed.
The filing does not provide revenue, profit, cash flow, or margin data for a specific reporting period.
Material Changes and Corporate Actions
Debt Restructuring (Item 1.01): The Company entered into a Pay-Off Letter and Conversion Agreement to restructure its relationship with its majority stockholder. This agreement is contingent on the closing of the IPO. Upon completion, the Convertible Debentures will terminate, and obligations will be cancelled, except for the payment of accrued interest.
Bylaws Amendment (Item 5.03): On June 13, 2016, the Board approved an amendment and restatement of the Company's Bylaws. Key changes include:
- Procedures for special stockholder meetings and advance notice provisions for director nominations.
- Clarification of the Company's election under Section 3-804(c) of the Maryland General Corporation Law.
- Provisions for emergency Board meetings and committee powers.
- Requirement that litigation regarding internal actions be brought in the Circuit Court for Baltimore City, Maryland, or the U.S. District Court for the District of Maryland.
Outlook, Risks, and Contingencies
Contingencies: The debt pay-off and conversion are strictly subject to the closing of the Company's IPO. If the IPO does not close, the terms of the Pay-Off Letter and Conversion Agreement regarding the $10 million cash payment and the conversion of the remaining principal may not be executed as described.
Management Commentary: The filing indicates the Company has applied to list its common stock on the New York Stock Exchange. The Bylaws amendments were made to ensure consistency with Maryland law and NYSE listing requirements.
Risks: The filing does not explicitly list risk factors beyond the contingency of the IPO closing for the debt agreement.
Investor Verification Checklist
- Verify the final closing date and terms of the underwritten public offering (IPO) to confirm the trigger for the debt pay-off and conversion.
- Confirm the exact number of shares and units to be issued upon conversion of the $15,030,134 remaining principal at the $12.748 rate.
- Review the full text of the Second Amended and Restated Bylaws (Exhibit 3.1) for specific governance implications.
- Monitor the daily accrual of interest ($5,486.06) to estimate the total interest liability at the time of IPO closing.
- Confirm the Company's listing status on the New York Stock Exchange.